RARE earnings

Catalyst

RARE earnings

RARE earnings — 2026-05-05

Reported the quarter ending 2026-03-31: revenue $136M, diluted EPS $-1.84, net income $-185M (SEC filing). Across the print the stock moved +4.5% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

10 events
DateTypeEvent
Apr 28 ScanBiotech Scan Apr 26 ScanBiotech Scan May 29 ScanBiotech Scan Mar 26 ScanBiotech Scan Mar 24 ScanBiotech Scan Jun 16 ScanBiotech Scan Mar 20 ScanBiotech Scan Jun 25 ScanBiotech Scan Jun 26 ScanBiotech Scan Mar 13 ScanBiotech Scan

No direct external sources are attached to this read.